Member Info for Miggy007

Very surprised that GDR only have 1million in sales arranged thus far. Was an investor here and I believe the product is a top one. Sales team need a rocket. Fortunes could very well turn around when second wave becomes evidential. GL to all who still hold here, hope they land some juicy contracts.

Brokers forecasts should always be taken with a pinch of salt. Unless there is a result soon???. Is two weeks or so too long to wait for you?. Please. The 5%’s if they have managed to do that may just regret having a little more patience :)

I personally think it’s a better chance than a 50/50. Even taken as a 50% chance it would still be a great bet. The downside is probably 10-15p the upside is north of 120p or more. From the current SP that makes it a no brainer. The reward is there.

I don't think it will be a binary result regards hospital trials. More likely to be a sliding scale dependant on severity, co-morbidities, infection stage and so on. What it should give them is clear data as to drop off effectiveness of drug and strongly hint at benefit when given earlier in the virus cycle. For me, hospital trial results showing a drop in hospital stay duration by 20% or more would be a good result. Home trials would, then, i believe show a significantly higher effectiveness over and well above 35%. The real potential of this treatment is in the home setting. Professor Holgate et al know this. Multiple benefits: infection spread is kept to a minimum. People can remain in their own homes (whilst taking two week treatment) taking pressure off NHS. Home kits can be delivered/posted to sick clients pretty much anywhere. Moving forward the drug could well be safely used alongside another drug which kills the virus. Then you have the game changer. A drug that suppresses replication and boosts the general immune system with a drug that kills virus cells. Eradication of the virus from hosts bodies will then speed dramatically in the right direction.

Really hope that with swimming pools and gyms reopening doesn't mean that saunas and steam rooms will reopen too. That would be a very bad move. I got the impression that SNG, subject to things going well, would ideally want to be in position by September/October to combat the potential second wave. Quite a journey in a relative short space of time.

Filtered! I cant read your negative nonsense anymore Sebbedy:)

Newbie- I filtered Seb's nonsense weeks ago. I have to be honest. I really don't miss his contributions :)

JBER moved off the sell at 38p and created a bit of free movement. They are still sat there at 39p though so it maybe no big deal and volume was low too. About 860,000 at close. Probably not the second coming but always nice to see a blue finish.

Would appear to be positive development regarding Merck and INF B1a. Maybe the EU wanted to gobble up all the doses of this product before the US jumped in. I think the SNG nebuliser will be the best delivery method. Firstly, you are directly targeting the organ where the infection is. Secondly by applying direct to this region maximum impact will be attained by using a lower dosage than a systemic delivery via injection. This could certainly have a cost impact as less INF B1a would be required. Also less side effects due to lower dosage. It’s winner winner in that respect.

I think some investors here need to keep it together. Nolupus, to be fair to SNG they did state part of the reason COPD data was unblinded was to support the COVID trial data. Support not stand alone. It wouldn’t be outrageous if both came together. You seem to suggest and have done forever that they are being disingenuous by not releasing the COPD data. All good things to those who wait. And as regards rushing these trials. I understand the need but it just cannot be done. How can you rush a drug through to market before it’s even proven efficacy. RM said ages ago that drugs will get rushed through but they and many others would and have fallen by the wayside. What do we have thus far? Remdesivir which doesn’t strike me as a game changer. No vaccine. SNG have done it right in incredibly difficult circumstances and hopefully will get the reward.

Even if hospital trial isn’t a complete success, which I don’t expect tbh I’d expect a little more feedback than ‘er, yeah, I think we introduced it too late’ ffs

Ah Nolupus, I remember when you turned up here all blue eyed and bushy tailed. You did become less passive deramper, over time, to reflect your holding probably. I don’t believe I’m a ramper. I’m a holder for good or worse. My outlook and stance hasn’t changed from day one. I don’t think anyone’s opinion on here alters the SP anyways. Also think much of what has needed to be said and shared has already been done here so like many others just waiting for results now. No bull****, no bluster, just waiting.:)

Chrishar- still time for it to pick up before results. it would appear end of July or from about 20th or thereabouts will be hospital trial results. I would hope we would get COPD no later than these results too. I’m not into predicting SP’s or timelines too much. SP thus far has not performed as we would have liked but I just go back to fundamentals. Some of the best minds in respiratory viruses are involved with Synairgen. They’ve been developing the drug for some time now. They know far more about it than any of us. Would Professor Holgate and Co have wasted 12+ years on this project if they thought it was a lame duck. I’m willing to wager not.

Just got in from work but I see JBER are still sat on the sell same as the end of last week. I would imagine this is Acacia selling. Soon as they are done we should be ok. Hopefully the churn picks up and we get rid of them once and for all soon. :)

Gkb- you do seem to have been going on about this for ages. It doesn’t bother me in the slightest that results slipped a month. I think people need to get a grip. As someone posted earlier they are doing in a matter of months what would normally take years to achieve. Think you need to take a step back and gain some perspective tbh.

Gkb- it does, but what I was trying to say was that the virus gains entry via the lungs to potentially spread to other organs. SNG’s direct application to the lungs could prevent this progression. You wouldn’t then need to inject anything and the unpleasantness that brings on.

Thing with Faron is that it would appear to be targeted more towards the systemic problem once the virus has taken hold. Injecting Interferon in this way will increase side effects which can be serious in already sick patients. The beauty of SNG001 is as we all know is that it is delivered directly to the lungs thus avoiding direct entry to the avascular network. If You block the virus penetrating the lining of the lungs, then you can stop avascular entry and someone progressing onto that bad second or third week hopefully.

In so far as the Company is aware, the percentage of the Company’s issued share capital that is not in public hands is 14.3%. This percentage comprises the holding of Lansdowne Partners and the directors’ beneficial holdings of 2.6%.

Interesting that Synairgens home page seems to have updated the shareholding’s but in the column to the left, which is copied above, it doesn’t take into account Acacia’s holding. It does have them down as holding 7.5% In the list though. Maybe just not been updated.

187,000 at 41.75 blows JBER away :)

Boom that’s unlocked it :)